R406
-
- Category :
Pharmaceuticals and Biochemicals
- CAS NO : 841290-80-0
- EC NO :
- Molecular Formula :
- Main Specifications : 98%
- Synonyms :
Package: As customer request
Uses : Intermediate used for preparation of prodrugs of pyrimidine-2,4-diamines as anticancer agents.
Product description:
Product Name: R-406
CAS: 841290-80-0
Synonyms: 6-[5-Fluoro-2-(3,4,5-trimethoxy-phenylamino)-pyrimidin-4-ylamino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one;6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one;R406(free base);R-406 6-[[5-Fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one;R406 (free base), >=98%
MF: C22H23FN6O5
MW: 470.459
EINECS: 617-533-5
Uses
1. Intermediate used for preparation of prodrugs of pyrimidine-2,4-diamines as anticancer agents.
2. R406 is a potent ATP-competitive inhibitor of spleen tyrosine kinase (Syk, Ki = 30 nM). Through this action, R406 blocks FcεRI-dependent mast cell activation (EC50 = 43 nM) and, at 3 μM, reduces the release of IL-10, -12, and -13 by immune complex-pulsed dendritic cells. R406 is orally available and can reduce immune complex-mediated inflammation. In cancers characterized by over-expression of Syk, R406 can prevent signaling downstream of Syk and induce apoptosis. R406 also inhibits Syk-dependent signaling through c-Jun N-terminal kinase in rheumatoid arthritis synoviocytes, suggesting a therapeutic intervention in this autoimmune disease.[Cayman Chemical]